Numerous studies suggest PrPC may play a role in Alzheimer's disease (AD), and there is evidence that PrP can modulate the production, aggregation and toxicity of the amyloid β-protein (Aβ) [9–11]. The gene discussed is PRNP; the disease is early-onset autosomal dominant Alzheimer disease.